Prof. Monika I. Konaklieva is an Associate Professor of Chemistry in the Department of Chemistry at an American university. She received an MS in Pharmacy from State University Medical Academy, and Chemistry from the Institute of Organic Chemistry, Sofia, Bulgaria, and a PhD in Synthetic Organic Chemistry from the State University of New York at Buffalo (1997). Her research involves the design, synthesis and evaluation of biologically active agents. Current projects focus on exploring different approaches for delaying microbial resistance, including fragment-based structure-activity studies aimed at improving the therapeutic efficacy of lead compounds. Collaborations exist with several research groups at the NIH and Midwestern University.  She is a Fellow of the American Chemical Society, The Scientific Research Honor Society Sigma-Xi and the American Association for the Advancement of Science.